MedTrace Logo

Trial for the Treatment of Alcohol Dependence

NCT00120601 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2005-07-18

No results posted yet for this study

Summary

The purpose of this study is to compare the effectiveness of two anti-craving medications, naltrexone versus acamprosate, in the treatment of alcohol dependence.

Conditions

  • Alcoholism

Interventions

DRUG

Naltrexone

DRUG

Acamprosate

Sponsors & Collaborators

  • National Health and Medical Research Council, Australia

    collaborator OTHER

  • Sydney South West Area Health Service

    collaborator OTHER_GOV

  • South Eastern Area Health Service

    collaborator OTHER

  • Wentworth Area Health Services

    collaborator OTHER

  • University of Sydney

    lead OTHER

Principal Investigators

  • Paul Haber, MBBAMDFRACP · Conjoint Associate Professor

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-03-31
Completion
2005-06-30

Countries

  • Australia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00120601 on ClinicalTrials.gov